C12N 2800/10
Plasmid dna
Official title: Plasmid DNA
C12N2800/10 (Plasmid dna) appears on 941 US grants and 1,750 published applications in this corpus.
Search patents in C12N- Granted patents
- 941
- Published applications
- 1,750
- Assignees
- 1,020
- Inventors
- 4,385
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 2 | 0 |
| 1991 | 3 | 0 |
| 1992 | 1 | 0 |
| 1993 | 6 | 0 |
| 1994 | 4 | 0 |
| 1995 | 4 | 0 |
| 1996 | 10 | 0 |
| 1997 | 31 | 0 |
| 1998 | 40 | 0 |
| 1999 | 14 | 0 |
| 2000 | 25 | 0 |
| 2001 | 17 | 8 |
| 2002 | 25 | 31 |
| 2003 | 30 | 54 |
| 2004 | 10 | 34 |
| 2005 | 18 | 42 |
| 2006 | 12 | 35 |
| 2007 | 25 | 29 |
| 2008 | 16 | 32 |
| 2009 | 16 | 29 |
| 2010 | 16 | 33 |
| 2011 | 22 | 38 |
| 2012 | 30 | 36 |
| 2013 | 23 | 26 |
| 2014 | 26 | 32 |
| 2015 | 32 | 44 |
| 2016 | 21 | 36 |
| 2017 | 26 | 42 |
| 2018 | 33 | 43 |
| 2019 | 27 | 51 |
| 2020 | 22 | 68 |
| 2021 | 33 | 70 |
| 2022 | 41 | 225 |
| 2023 | 54 | 222 |
| 2024 | 64 | 170 |
| 2025 | 84 | 161 |
| 2026 | 77 | 159 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- System and method for increased alcohol tolerance and production in yeast29 Sep 2026US 12,747,459 B2Kyoto University
- Ketoreductase mutant and method for producing chiral alcohol29 Sep 2026US 12,747,460 B2Asymchem Laboratories (Fuxin) Co., Ltd.
- Method of preparing circular permutation-based functional recombinant human-derived fibroblast growth factor 7 and use thereof15 Sep 2026US 12,735,465 B2Industry Foundation of Chonnam National University
- Engineered strains of Corynebacteria15 Sep 2026US 12,735,730 B2
- Compositions and production of nicked closed-ended DNA vectors8 Sep 2026US 12,729,386 B2Generation Bio Co.
- Anti-vegf protein compositions and methods for producing the same8 Oct 2026US 2026/0308231 A1Regeneron Pharmaceuticals, Inc.
- Anti-vegf protein compositions and methods for producing the same8 Oct 2026US 2026/0308232 A1Regeneron Pharmaceuticals, Inc.
- Anti-vegf protein compositions and methods for producing the same8 Oct 2026US 2026/0308233 A1Regeneron Pharmaceuticals, Inc.
- New high expression and high activity n-glycosidases, methods of production and applications thereof8 Oct 2026US 2026/0308562 A1Centre National de la Recherche Scientifique (CNRS)
- Kinetically controlled methods to prepare concentrated shelf-stable nucleic acid transfection vehicles8 Oct 2026US 2026/0308631 A1The Johns Hopkins University
Most cited
By later US patents
- CRISPR-Cas component systems, methods and compositions for sequence manipulation560US 8,795,965 B2Massachusetts Institute of Technology · 2014
- CRISPR-Cas component systems, methods and compositions for sequence manipulation529US 8,871,445 B2Massachusetts Institute of Technology · 2014
- Engineering of systems, methods and optimized guide compositions for sequence manipulation480US 8,906,616 B2Massachusetts Institute of Technology · 2014
- Genetic constructs for delaying or repressing the expression of a target gene369US 6,573,099 B2Benitec Australia Limited · 2003
- Preparation of functional human factor VIII in mammalian cells using methotrexate based selection276US 4,965,199 AGenentech, Inc. · 1990